Keep up with the fast pace of COVID-19 research with a series of concise “Science Spotlight” commentaries and audio podcasts featuring a pair of experts discussing the most clinically relevant new COVID-19 data.
Here are my thoughts on how developing data may help you assess immunocompromised patients’ risk of severe COVID-19 illness.
Navigating what is currently known about responsiveness to COVID-19 vaccines and the potential for SARS-CoV-2 variants in immunocompromised patients.
Neutralizing antibodies are an attractive strategy for prevention and treatment of COVID-19, particularly for unvaccinated persons and others at high risk of infection. Here’s my take on 2 exciting new studies in this field.